INTERMACS profiles of advanced heart failure: the current picture.

By L. Stevenson, F. Pagani, James B. Young, M. Jessup, L. Miller, R. Kormos, D. Naftel, K. Ulisney, P. Desvigne‐Nickens, J. Kirklin. The Journal of Heart and Lung Transplantation, 2009

731 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/8b63fee4029726c364ca987a5ea045594c05fc83

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. S. Naidu
2. N. K. Lakdawala
3. Jeffery Winterfield
4. Birgit Funke

Citations in the corpus

• Dilated Cardiomyopathy (2007, positive): “An important contribution to evaluation for candidacy to LVAD was the introduction of the INTERMACS classification, which categorizes patients for the purpose of risk assessment prior to LVAD implant or HT [79], ranging from 1 (cardiogenic shock) to 7 (advanced NYHA III), and describes patient’s cli”
• SCAI clinical expert consensus statement on the classification of cardiogenic shock (2019, background): “Heart Association (ACC/AHA) classification of HF and the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) classification.(11,12) The INTERMACS classification is particularly useful due to key “tags” which serve as memorable ways to categorize patients.”